by the hemostatic
system, characterized by sensitivity and variability of the
effects in response to any
impact
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) , tumorigenicity, reproductive
effects, irritating
effects), low toxicity (class IV-V), and acceptable oral
/kg) exhibited antidepressant-like
effects at doses equimolar to amitriptyline (10 mg/kg); IId (2 mg/kg) and IIb
URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) There are no recommendations for assessing the
effect of potential drugs on the hemostatic system
Spasov, A.A.,
Khaliullin, F.A.,
Babkov, D.A.,
Timirkhanova, G.A.,
Kuznetsova, V.A.,
Naumenko, L.V.,
Muleeva, D.R.,
Maika, O.Yu.,
Prokhorova, T.Yu.,
Sturova, E.A. (2017) synthesized here had no
effects on protein glycation reactions using glucose; they gave weak inhibition
in medical practice to control bleeding are often inefficient and unable to lead to
effective reduction
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) -nitro-1-(thietan-3-yl)-1H-pyrazol-5-yl]amino}ethan-1-ol with an antiplatelet
effect. Results